Gilead Sciences (GILD) 2025 Conference Transcript

Gilead Sciences (GILD) 2025 Conference May 13, 2025 02:20 PM ET Speaker0 For joining us, I'm Tim Anderson, the US large cap pharma and biotech analyst of Bank of America, and excited to have Gilead with us today, specifically Joanna Mercer, who serves as the company's Chief Commercialization Officer overseeing the global commercialization of the company's medicines across really all areas. She's been with the company since 2019. Prior to Gilead, I think twenty five years at Bristol Myers, so quite a long ti ...